Non-Hodgkin's lymphoma and skin cancer

doi:10.1136/bmj.311.7007.749a

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Peter Sasieni, Research scientist,
Veronique Bataille, Senior registrar

Department of Mathematics, Statistics, and Epidemiology, Imperial Cancer Research Fund, PO Box 123, London WC2A 3PX
Department of Dermatology, St George's Hospital, London SW17 0RE

Ultraviolet light is unlikely explanation for association

EDITOR,--Johanna Adami and colleagues provide data showing a greatly increased risk of melanoma and squamous cell skin cancer after non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.1 They also show a smaller but significantly increased risk for the reverse (non-Hodgkin's lymphoma and chronic lymphocytic leukaemia after skin cancer). They conclude that “this supports the hypothesis of a role for ultraviolet light in the increasing incidence …